Expands opioid settlement reach to supply chain

The New York Legislature approved file S06757 ("Expands opioid settlement reach to supply chain"), by a recorded vote of 188 to 16. Last action: September 26, 2025.

New York file S06757, before the New York Legislature. Passed as of 2025-09-26.

What it does

More defendants means larger settlement funds for your state By clarifying that distributors, marketers, and payment processors in the drug supply chain are covered by settlement agreements, states may recover additional damages from entities previously excluded, increasing resources available for addiction treatment and prevention programs.

The bigger picture

Shifts liability across entire pharmaceutical distribution network The clarification holds accountable not just manufacturers but also wholesalers, pharmacies, and third-party payers involved in promoting or profiting from opioid sales, potentially deterring similar conduct in future drug markets beyond opioids.

What to watch

Settling entities may dispute application of clarified scope Companies already settled under older agreements may argue the clarification should not retroactively expand their liability, leading to litigation over how broadly 'supply and payment chain' entities are interpreted and applied.

How they voted

Yes (188)

No (16)

Did not vote / other (9)

Read the official record for S06757

See everything up for a vote · This week in New York · See what we have filed with the clerk